Active Cancer Biomarkers Grants

PI Namesort descending Organization - Company Title Major Program / Research Group FOA
Abbott, Karen L. Florida International University Novel Platform linking cancer-specific glycosylation with cell signaling outcomes Innovative Technology Development for Cancer Research RFA-CA-17-010: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Abbott, Karen L. Florida International University Glycomics Laboratory for the Development of Ovarian Cancer Biomarkers Alliance of Glycobiologists for Cancer Research PA-18-590: Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
Abrams, Julian Columbia University Health Sciences The Oral Microbiome for the Detection of Barretts Esophagus PA-18-484: NIH Research Project Grant
Abyzov, Alexej Mayo Clinic Rochester Detection of somatic, subclonal and mosaic CNVs from sequencing PAR-15-331: Advanced Development of Informatics Technologies for Cancer Research and Management
Agarwal, Ashutosh University Of Miami School Of Medicine A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Ai, Huiwang University Of Virginia BapaFPs: Genetically encoded fluorescent indicators to image live-cell nucleotide sugars RFA-RM-17-030: Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions
Almonte, Maribel International Agency For Res On Cancer Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries RFA-CA-15-001: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3)
Amos, Christopher I Baylor College Of Medicine Coordinating Center: Molecular and Cellular Findings of Screen-Detected Lesions Molecular and Cellular Characterization RFA-CA-14-011: Molecular and Cellular Characterization of Screen-Detected Lesions - Coordinating Center and Data Management Group
Amster, I Jonathan University Of Georgia An Automated Platform for the CE-MS Analysis of Glycosaminoglycans RFA-RM-17-029: Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans
Anderson, Karen S. Arizona State University-Tempe Campus Rapid Point of Care Detection of HPV-Associated Malignancies RFA-CA-15-024: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UG3/UH3)
Angel, Peggy M Medical University Of South Carolina Enzymatic Tools for 2D Tissue Localized and Deeper Proteomic Sequencing of Cancer Stromal Proteins RFA-CA-18-002: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Balbo, Silvia University Of Minnesota The DNA adductome of lung carcinogenesis PAR-15-308: Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention
Barton, Jennifer Kehlet University Of Arizona Molecular and Imaging Assessment of Fallopian Tube Health PAR-16-176: NCI Clinical and Translational Exploratory/Developmental Studies
Basen-Engquist, Karen M American Society Of Preventive Oncology, Inc. 2021 Annual Conference Grant: American Society of Preventive Oncology PA-20-207: NIH Support for Conferences and Scientific Meetings
Bast, Robert C University Of Tx Md Anderson Can Ctr MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer Early Detection Research Network, EDRN Clinical Validation Center RFA-CA-14-015: The Early Detection Research Network: Clinical Validation Centers